Search

Your search keyword '"Isernia G"' showing total 168 results

Search Constraints

Start Over You searched for: Author "Isernia G" Remove constraint Author: "Isernia G"
168 results on '"Isernia G"'

Search Results

1. Urgent endovascular repair of juxtarenal/pararenal aneurysm by off-the-shelf multibranched endograft

3. RANDOMisation Screening for Drug coated or Drug Eluting Device Randomised Trials Among Patients Undergoing Endovascular FemorOPopliteal Procedures (RANDOM-STOP study)

5. Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation

11. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

12. RANDOMisation Screening for Drug coated or Drug Eluting Device Randomised Trials Among Patients Undergoing Endovascular FemorOPopliteal Procedures (RANDOM-STOP study)

13. Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials

15. Acquiring competencies in cerebral ultrasonography: a pragmatic study

16. Impact of frailty on traumatic brain injury outcome. Data from CENTER‑TBI

17. Intracranial pressure management in acute brain‑injured patients: baseline characteristics of the Synapse‑ICU Centers ESICM LIVES 2020

18. Practice of ICP monitoring in acute brain‑injured patients: results from the Synapse‑ICU study

19. One-year experience of a regional service model of teleconsultation for planning and treatment of complex thoracoabdominal aortic disease

31. HERMES: A new stand-alone platform for active noise control and damage detection

32. How to perform endovascular carotid revascularization

34. Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells

35. Differential sensitivity to non-MHC-restricted rIL-2 activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or PKA subunits

36. Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells

37. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors

38. The cAMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors

40. Both Historical and Procedural Staging Reduce Spinal Cord Ischaemia Rates After Elective Fenestrated and Branched Endovascular Treatment of Extensive Thoraco-Abdominal Aortic Aneurysms in a Multicentre Registry

43. Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells

45. Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits

46. Results of the 'endovascular treatment first' policy for infrapopliteal disease

49. Plaque debulking for femoro-popliteal occlusions: Techniques and results

Catalog

Books, media, physical & digital resources